Eyigor 2009.
Methods | Type of study: RCT | |
Participants | Number of participants randomised: 40 Losses: 3 (1 exercise, 2 control) Age: over 65 years (mean 73.5 exercise, 71.2 control) Sex: women Residential status of participants: community dwelling Health status as defined by authors: healthy Setting: Turkey Inclusion: over 65 years, physically active Exclusion: neurological impairment, severe cardiovascular disease, unstable chronic or terminal illness, major depression, severe cognitive impairment or musculoskeletal impairment. |
|
Interventions | EXERCISE GROUP (3D) (n = 19): The dance‐sessions were divided into the following three sections: a warm‐up period, a special folklore dance stepping period, a stretching and a cool‐down period. During movement to movement knees were regularly flexed, shoulders were elevated and depressed and participants walked in a circle. CONTROL GROUP (n = 18): usual activity Duration and intensity: 1 hour sessions, 3 x week, 8 weeks, encouraged to walk half an hour twice a week Supervisor:senior folklore dance expert Supervision: group Setting: clinic | |
Outcomes | Gait 20 m (s) Berg Balance Score (score 0 ‐ 56) Compliance/adherence: not reported Adverse events: No adverse events reported. |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Randomisation mentioned but insufficient information about the sequence generation process to permit judgement |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgement |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | ‘As‐treated’ analysis done, drop outs reported |
Selective reporting (reporting bias) | Unclear risk | Insufficient information to permit judgement |
Other bias | Low risk | The study appears to be free of other sources of bias |
Blinding (participant) | High risk | Not possible |
Blinding (assessor) | Unclear risk | Insufficient information to permit judgement |
Were the treatment and control group comparable at entry? | Low risk | No differences reported on baseline characteristics with a potential to influence the effect of the intervention |
Was the surveillance active, and of clinically appropriate duration (i.e. at least 3 months post intervention)? | High risk | Only immediately post intervention data, no follow‐up data reported. |